Clinical Trial: Gotistobart Long Term Extension (LTE) Study

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659379) titled 'Gotistobart Long Term Extension (LTE) Study' on June 15.

Brief Summary: This LTE study will examine the long-term overall survival and safety of gotistobart in patients with advanced solid tumors.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumor

Intervention: DRUG: Gotistobart

ONC-392 will be given following parent trial

Recruitment Status: NOT_YET_RECRUITING

Sponsor: OncoC4, Inc.

Disclaimer: Curated by HT Syndication....